|

Multicentric Database for KRAS Mutant Pancreatic Cancer

RECRUITINGSponsored by Fudan University
Actively Recruiting
SponsorFudan University
Started2026-05-22
Est. completion2028-04-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07557849

Summary

Construction and Maintenance of a Precision Subtyping-Based Clinical Cohort for Targeted Therapy in KRAS-Mutant Pancreatic Cancer

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* No restrictions on age, gender, or performance status score;

  * Pathologically or cytologically confirmed pancreatic adenocarcinoma; ③ Known KRAS mutation subtype and has received treatment with KRAS-targeted agents;

    ④ Able to comply with the study visit schedule requirements;

    ⑤ Voluntarily participate and sign the informed consent form.

Exclusion Criteria:

* Non-neoplastic pancreatic lesions;

  * Non-primary pancreatic neoplastic lesions; ③ Unable to comply with the study visit schedule requirements; ④ Refuse to participate and sign the informed consent form.

Conditions2

CancerPancreatic Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.